The Multiple Myeloma Research Foundation has produced the following MMRF Investors Series Videocasts. These multimedia presentations require the free Flash Player software.

Featured Presentations:
• Welcome and Overview of MMRF/MMRC
  Kathy Giusti, Founder & CEO, MMRF/MMRC


• MMRC Genomics Initiative
  Todd R. Golub, MD, Dana-Farber Cancer Institute, Broad Institute of Harvard & MIT


• Target and Lead Validation
  James E. Bradner, MD, Dana-Farber Cancer Institute, Broad Institute of Harvard & MIT


• Combination Validation
  William S. Dalton, PhD, MD, H. Lee Moffitt Cancer Center & Research Institute


• MMRF/MMRC - Semafore Partnership
  Joseph R. Garlich, PhD, President & Chief Scientist, Semafore Pharmaceuticals


• Novel and Combination Clinical Trials
  Kenneth C. Anderson, MD, Dana-Farber Cancer Institute, Harvard Medical School


• Industry Panel Discussion: Highlights of the MMRF/MMRC's Role in Drug Development
  Laurie A. Kunkel, MD, Proteolix, Inc.
  August J. Salvado, MD, Novartis Pharmaceuticals Corporation
  Peter Sportelli, Keryx Biopharmaceuticals, Inc.


• Perifosine
  Peter Sportelli, Keryx Biopharmaceuticals, Inc.


• A Tale of Two Hopes
  Clinton Leaf, Author, "Why We're Losing the War on Cancer (and How to Win It)"

Featured Presentations:
• Accelerating Drug Development
  Kathy Giusti, Founder & CEO, MMRF/MMRC


• Semafore and "Venture Phinanthropy"
  Joseph R. Garlich, PhD, President & Chief Scientist, Semafore Pharmaceuticals